These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18088548)

  • 41. Effect of early initiation of highly active antiretroviral therapy on CD4 cell count and HIV-RNA viral load trends within 24 months of the onset of acute retroviral syndrome.
    Voirin N; Routy JP; Smith D; Baratin D; Trépo C; Cotte L; Touraine JL; Livrozet JM; Cooper DA; Ritter J; André P; Vanhems P
    HIV Med; 2008 Jul; 9(6):440-4. PubMed ID: 18705761
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunological responses during a virologically failing antiretroviral regimen are associated with in vivo synonymous mutation rates of HIV type-1 env.
    Mens H; Jørgensen LB; Kronborg G; Schønning K; Benfield T
    Antivir Ther; 2009; 14(3):413-22. PubMed ID: 19474475
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antiretroviral and statin drug-drug interactions.
    Ray GM
    Cardiol Rev; 2009; 17(1):44-7. PubMed ID: 19092370
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
    J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
    Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
    Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Response to HAART in French patients with resistant HIV-1 treated at primary infection: ANRS Resistance Network.
    Chaix ML; Desquilbet L; Descamps D; Costagliola D; Deveau C; Galimand J; Goujard C; Signori-Schmuck A; Schneider V; Tamalet C; Pellegrin I; Wirden M; Masquelier B; Brun-Vezinet F; Rouzioux C; Meyer L; ;
    Antivir Ther; 2007; 12(8):1305-10. PubMed ID: 18240870
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of the factors involving in the development of hypothyroidism in HIV-infected patients: a case-control study.
    Afhami S; Haghpanah V; Heshmat R; Rasoulinejad M; Izadi M; Lashkari A; Tavangar SM; Hajiabdolbaghi M; Mohraz M; Larijani B
    Infection; 2007 Oct; 35(5):334-8. PubMed ID: 17885731
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.
    Lima VD; Harrigan R; Murray M; Moore DM; Wood E; Hogg RS; Montaner JS
    AIDS; 2008 Nov; 22(17):2371-80. PubMed ID: 18981777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disease progression in HIV-1 infected children and adolescents--results of a German-Austrian cohort study.
    Funk MB; Buchholz B; Notheis G; Neubert J; Feiterna-Sperling C; Ganschow R; Simon T; Hornemann F; Peters AM; Rütschle H; Horneff G; Lechner E; Hanschmann KM; Wintergerst U;
    Eur J Med Res; 2008 Aug; 13(8):371-8. PubMed ID: 18952519
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reconstitution of herpes simplex virus-specific T cell immunity in HIV-infected patients receiving highly active antiretroviral therapy.
    Ramaswamy M; Waters A; Smith C; Hainsworth E; Hardy G; Johnson M; Ainsworth J; Phillips A; Geretti AM
    J Infect Dis; 2007 Feb; 195(3):410-5. PubMed ID: 17205480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetic interactions between statins and fibrates.
    Corsini A; Bellosta S; Davidson MH
    Am J Cardiol; 2005 Nov; 96(9A):44K-49K; discussion 34K-35K. PubMed ID: 16291014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Metabolic abnormalities, lipodystrophy and cardiovascular risk in HIV-infected patients].
    Leclercq P; Blanc M
    Rev Prat; 2006 May; 56(9):987-94. PubMed ID: 16775979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of metabolic drugs and fish oil in HIV-positive patients with metabolic complications and associations with dyslipidaemia and treatment targets.
    Normén L; Yip B; Montaner J; Harris M; Frohlich J; Bondy G; Hogg RS
    HIV Med; 2007 Sep; 8(6):346-56. PubMed ID: 17661842
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune recovery in HIV with Mycobacterium W.
    Kharkar R
    J Indian Med Assoc; 2002 Sep; 100(9):578-9. PubMed ID: 12455393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serological response to pneumococcal vaccination in HAART-treated HIV-infected patients: one year follow-up study.
    Falcó V; Jordano Q; Cruz MJ; Len O; Ribera E; Campins M; Crespo M; Ocaña I; Rodrigo MJ; Pahissa A
    Vaccine; 2006 Mar; 24(14):2567-74. PubMed ID: 16423429
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immune reconstitution in HIV infection.
    Gea-Banacloche JC; Clifford Lane H
    AIDS; 1999; 13 Suppl A():S25-38. PubMed ID: 10885760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of "HAART" on CD4+ T lymphocyte counts in HIV seropositive south-Indian individuals--a follow up study.
    Shahapur PR; Bairy I; Shivananda PG
    Indian J Pathol Microbiol; 2005 Apr; 48(2):270-2. PubMed ID: 16758693
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals.
    Cole MA; Margolick JB; Cox C; Li X; Selnes OA; Martin EM; Becker JT; Aronow HA; Cohen B; Sacktor N; Miller EN;
    Neurology; 2007 Dec; 69(24):2213-20. PubMed ID: 17914066
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of protective antibody against measles in HIV-infected children with immune recovery after highly active antiretroviral therapy.
    Aurpibul L; Puthanakit T; Siriaksorn S; Sirisanthana T; Sirisanthana V
    HIV Med; 2006 Oct; 7(7):467-70. PubMed ID: 16925733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Polylactic acid injections: usefullness for the treatment of facial lipoatrophy in HIV+ patients under tritherapy].
    Piquet M; Brignol L; Chatelain B; Rey D; Ricbourg B; Meyer C
    Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):496-504. PubMed ID: 17675198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.